Simon C Lowry
CIK 2044279 · SVP, R&D, CMO · last filed 2026-05-01
Simon C Lowry is a SVP, R&D, CMO who has filed 5 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing, for EBS, was dated May 1, 2026. Current disclosed insider exposure totals $1.1M across reported positions. 6 SEC filings were submitted jointly with Emergent BioSolutions Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.11M
1
5
$0
Filer Profile
GAITHERSBURG, MD 20879
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EBS | SVP, R&D, CMO | 177,914 | $6.23 | $1.11M | $0 | 5 | 2026-05-01 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-01 | EBS | Grant (A) | +100,111 | $0 | EDGAR |
| 2026-03-05 | EBS | Mixed | −10,636 | -$89.8K | EDGAR |
| 2025-12-16 | EBS | Tax (F) | −3,543 | -$40.4K | EDGAR |
| 2025-03-10 | EBS | Grant (A) | +62,500 | $0 | EDGAR |
| 2024-12-17 | EBS | Grant (A) | +29,482 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.